The ICSD‐3‐TR formally distinguishes between NT1 (requiring either cataplexy or low CSF hypocretin) and NT2 (EDS and MSLT findings without cataplexy and with normal or unmeasured hypocretin) (Ruoff and Rye 2016). Here, HCRT is linked to Cataplexy.